Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00236067

Public ClinicalTrials.gov record NCT00236067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 7, 2026, 8:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril(up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).

Study identification

NCT ID
NCT00236067
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
440 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Not listed
Completion
Mar 2006 (Type not available)
Last update posted
May 9, 2014

2004 – 2006

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama 35216 —
Southwestern Research Institute Beverly Hills California 90210 —
Pharmacology Research Institute Northridge California 91324 —
Pacific Clinical Research Orange California 92868 —
Carman Research Smyrna Georgia 30080 —
Hawaii Clinical Research Center Honolulu Hawaii 96826 —
Hartford Research Group Florence Kentucky 41042 —
Summit Research Network Okemos Michigan 48864 —
CNS Research Institute Clementon New Jersey 08021 —
Social Psychiatry Research Inst. Brooklyn New York 11235 —
Neurobehavioral Research, Inc. Lawrence New York 11559 —
Social Psychiatry Research Inst. New York New York 10021 —
The Medical Research Network New York New York 10024 —
Northcoast Clinical Trials Beachwood Ohio 44122 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Summit Research Network Portland Oregon 97209 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Carolina Clinical Research Services Columbia South Carolina 29201 —
Radiant Research, Salt Lake City Salt Lake City Utah 84107-7591 —
Comprehensive Neuroscience of Northern Virginia Arlington Virginia 22201 —
Summit Research Network Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00236067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →